Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Mantle-Cell 1

Interventions

Carboplatin 14 pembrolizumab 12 Gemcitabine 11 Cisplatin 11 Rituximab 8 durvalumab 7 Pemetrexed 6 Nivolumab 6 osimertinib 5 atezolizumab 5 Specimen Handling 5 Paclitaxel 5 Dexamethasone 5 amivantamab 4 Prednisone 4 Ipilimumab 4 Cyclophosphamide 4 Bortezomib 4 Bendamustine Hydrochloride 4 tremelimumab 3 trastuzumab deruxtecan 3 olaparib 3 niraparib 3 lazertinib 3 entrectinib 3 enfortumab vedotin 3 daratumumab 3 belzutifan 3 alectinib 3 acalabrutinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × brexucabtagene autoleucel × 90 days × Clear all

NCT02601313 2026-03-18

ZUMA-2

Gilead Sciences

Phase 2 Completed

105 enrolled 33 charts 1 FDA

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡